Literature DB >> 20839488

Cytokine gene polymorphisms and risk for upper respiratory symptoms in highly-trained athletes.

Amanda J Cox1, Maree Gleeson, David B Pyne, Robin Callister, Peter A Fricker, Rodney J Scott.   

Abstract

Physiological and immunological factors contributing to risk for upper respiratory symptoms (URS) in athletic populations remain under investigation. Single nucleotide changes (polymorphisms) in cytokine genes and alterations in associated gene expression may influence risk for URS in some athletes. The aim of this study was to compare the frequency of cytokine gene polymorphisms in athletes with or without a history of frequent URS. Cytokine gene polymorphisms were determined in samples from five previous investigations of immune function in highly-trained athletes (n=170). Participants were classified into two groups based on their self-reported number of episodes of URS in the preceding 12 months. Athletes were classified as healthy (n=82) if they reported < or =2 episodes of URS in the preceding 12 months. Athletes were classified as illness-prone (n=88) if reporting > or =3 episodes of URS. Polymorphisms in Interleukin (IL)-6, IL-8, IL-10, IL-1 receptor antagonist (IL-1ra), IL-2, IL-4 and Interferon(IFN)-gamma were determined using real-time polymerase chain reaction allelic discrimination assays. The distribution of genotype frequencies between the two groups was compared using a Chi-square test and logistic regression was used to model risk for URS as a function of cytokine gene polymorphisms. There was a tendency for IL-6 (chi2 = 5.0, p = 0.08) and IL-4 (chi2 = 4.8, p = 0.09) genotype frequencies to differ between the groups. The IL-6 high-expression genotype was associated with an increased likelihood of > or =3 URS episodes in a 12 month period (odds ratio (OR): 2.87, 95% confidence interval (CI): 1.10-7.53; p = 0.03). The IL-2 high-expression genotype was associated with a tendency for a decreased likelihood of > or =3 URS episodes in a 12 month period (OR: 0.361, 95% CI: 0.124-1.06; p = 0.06). These data suggest cytokine gene polymorphisms may account in part for differences in risk for URS in highly-trained athletes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20839488

Source DB:  PubMed          Journal:  Exerc Immunol Rev        ISSN: 1077-5552            Impact factor:   6.308


  7 in total

Review 1.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

2.  Expression of SCGB1C1 gene as a potential marker of susceptibility to upper respiratory tract infections in elite athletes - a pilot study.

Authors:  J Orysiak; J Malczewska-Lenczowska; M Bik-Multanowski
Journal:  Biol Sport       Date:  2016-03-06       Impact factor: 2.806

3.  Upper Respiratory Tract Diseases in Athletes in Different Sports Disciplines.

Authors:  Anna Gałązka-Franta; Edyta Jura-Szołtys; Wojciech Smółka; Radosław Gawlik
Journal:  J Hum Kinet       Date:  2016-10-14       Impact factor: 2.193

4.  Training Load, Immune Status, and Clinical Outcomes in Young Athletes: A Controlled, Prospective, Longitudinal Study.

Authors:  Katharina Blume; Nina Körber; Dieter Hoffmann; Bernd Wolfarth
Journal:  Front Physiol       Date:  2018-03-23       Impact factor: 4.566

Review 5.  Environmental factors, immune changes and respiratory diseases in troops during military activities.

Authors:  Krzysztof Korzeniewski; Aneta Nitsch-Osuch; Andrzej Chciałowski; Jolanta Korsak
Journal:  Respir Physiol Neurobiol       Date:  2013-02-10       Impact factor: 1.931

Review 6.  Respiratory inflammation and infections in high-performance athletes.

Authors:  Maree Gleeson; David B Pyne
Journal:  Immunol Cell Biol       Date:  2015-11-16       Impact factor: 5.126

Review 7.  Behavioral strategies to prevent and mitigate COVID-19 infection.

Authors:  Noah T Hutchinson; Andrew Steelman; Jeffrey A Woods
Journal:  Sports Med Health Sci       Date:  2020-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.